PerioTrap Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC
  • (In Progress)

  • Latest Deal Amount
  • $3M

  • Investors
  • 10

PerioTrap General Information

Description

Operator of a biopharmaceutical company intended to eradicate the root cause of periodontitis. The company offers an anti-infective drug that is capable of targeting only the disease-causing pathogens and represents an effective alternative to classic broad-spectrum antibiotics, enabling physicians to prevent the recurrence of the disease easily.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Weinbergweg 22
  • 06120 Halle
  • Germany
+49 0345
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Weinbergweg 22
  • 06120 Halle
  • Germany
+49 0345

PerioTrap Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PerioTrap Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 06-Feb-2025 $3M In Progress Clinical Trials - General
8. Equity Crowdfunding 12-Feb-2025 Completed Clinical Trials - General
7. Equity Crowdfunding 08-Apr-2024 Completed Clinical Trials - General
6. Grant 16-Aug-2021 Completed Clinical Trials - General
5. Seed Round 03-Nov-2020 Completed Clinical Trials - General
4. Grant 17-Jun-2019 Completed Clinical Trials - General
3. Grant 19-Dec-2018 Completed Clinical Trials - General
2. Accelerator/Incubator Completed Clinical Trials - General
1. Accelerator/Incubator Completed Clinical Trials - General
To view PerioTrap’s complete valuation and funding history, request access »

PerioTrap Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PerioTrap Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Regional Development Fund (Brandenburg) Government
bmp Ventures Venture Capital Minority
Fraunhofer Venture Venture Capital Minority
Hemex (Healthcare Services) VC-Backed Company Minority
IBG Beteiligungsgesellschaft Sachsen-Anhalt Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

PerioTrap FAQs

  • When was PerioTrap founded?

    PerioTrap was founded in 2018.

  • Where is PerioTrap headquartered?

    PerioTrap is headquartered in Halle, Germany.

  • What is the size of PerioTrap?

    PerioTrap has 5 total employees.

  • What industry is PerioTrap in?

    PerioTrap’s primary industry is Drug Discovery.

  • Is PerioTrap a private or public company?

    PerioTrap is a Private company.

  • What is PerioTrap’s current revenue?

    The current revenue for PerioTrap is .

  • How much funding has PerioTrap raised over time?

    PerioTrap has raised $4.56M.

  • Who are PerioTrap’s investors?

    European Regional Development Fund (Brandenburg), bmp Ventures, Fraunhofer Venture, Hemex (Healthcare Services), and IBG Beteiligungsgesellschaft Sachsen-Anhalt are 5 of 10 investors who have invested in PerioTrap.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process